AN2 Therapeutics (ANTX) Shareholder's Equity (2021 - 2026)
AN2 Therapeutics (ANTX) Shareholder's Equity (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
502.95 Mn |
| 10 |
AN2 Therapeutics |
161.95 Mn |
161.95 Mn |
- |
81.76 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
81.76 Mn |
| Dec 31, 2025 |
53.06 Mn |
| Sep 30, 2025 |
60.38 Mn |
| Jun 30, 2025 |
68.84 Mn |
| Mar 31, 2025 |
73.33 Mn |
| Dec 31, 2024 |
81.85 Mn |
| Sep 30, 2024 |
87.67 Mn |
| Jun 30, 2024 |
98.35 Mn |
| Mar 31, 2024 |
110.60 Mn |
| Dec 31, 2023 |
124.70 Mn |
| Sep 30, 2023 |
138.97 Mn |
| Jun 30, 2023 |
87.76 Mn |
| Mar 31, 2023 |
82.52 Mn |
| Dec 31, 2022 |
95.37 Mn |
| Sep 30, 2022 |
105.57 Mn |
| Jun 30, 2022 |
115.86 Mn |
| Mar 31, 2022 |
115.41 Mn |
| Dec 31, 2021 |
-47.41 Mn |
| Sep 30, 2021 |
-38.35 Mn |
| Jun 30, 2021 |
-29.84 Mn |
